Jeevan Scienti. — 360° view

Jeevan Scienti, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹23 crore and net profit of ₹2.90 crore for the September 2026 quarter.

Jeevan Scienti. (BSE: JSTL) closed at ₹81.05 on 20 Nov 2026, up 31.0% over the past year. Its market capitalisation is ₹163 crore and it trades at 22.8 times earnings.

Share price
₹81.05 (20 Nov 2026)
Market cap
₹163 Cr (20 Nov 2026)
P/E
22.79 (20 Nov 2026)
Revenue
₹23 Cr (September 2026 quarter)
Net profit
₹3 Cr (September 2026 quarter)
ROCE
5.01% (FY26)
ROE
1.89% (FY26)
Book value
₹38.3 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹94.75 / ₹57.15 (20 Nov 2026)
1-year return
31.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Research, Analytics & Technology
Symbol
BSE: JSTL

Incorporated in 1999, Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutions

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.